The Effects of Dexmedetomidine on Cerebral Autoregulation and Cerebral Oxygenation in Subarachnoid Haemorrhage Patients

Trial Profile

The Effects of Dexmedetomidine on Cerebral Autoregulation and Cerebral Oxygenation in Subarachnoid Haemorrhage Patients

Completed
Phase of Trial: Phase I/II

Latest Information Update: 08 Feb 2017

At a glance

  • Drugs Dexmedetomidine (Primary)
  • Indications Aneurysm; Subarachnoid haemorrhage
  • Focus Pharmacodynamics
  • Most Recent Events

    • 03 Feb 2017 Status changed to completed.
    • 28 Apr 2016 Planned primary completion date changed from 1 May 2016 to 1 Dec 2016.
    • 23 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top